カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のニカルジピン塩酸塩注射市場2022年：20 mg / 200 mL、 40 mg / 200 mL

◆英語タイトル：Global Nicardipine Hydrochloride Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8904）◆商品コード：GIR22MY8904
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：106
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ニカルジピン塩酸塩注射市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のニカルジピン塩酸塩注射の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ニカルジピン塩酸塩注射市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・20 mg / 200 mL、 40 mg / 200 mL

用途別セグメントは次のように区分されます。
・病院、クリニック、リカバリーセンター

世界のニカルジピン塩酸塩注射市場の主要な市場プレーヤーは以下のとおりです。
・Baxter、Hikma、Mylan、Sun Pharma、Chiesi、Wockhardt、DMS Pharmaceutical、Sandoz、Navinta、Teva、Shanghai Furen Medicine

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ニカルジピン塩酸塩注射製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なニカルジピン塩酸塩注射メーカーの企業概要、2019年～2022年までのニカルジピン塩酸塩注射の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なニカルジピン塩酸塩注射メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ニカルジピン塩酸塩注射の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのニカルジピン塩酸塩注射の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのニカルジピン塩酸塩注射市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびニカルジピン塩酸塩注射の産業チェーンを掲載しています。
・第13、14、15章では、ニカルジピン塩酸塩注射の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Baxter、Hikma、Mylan、Sun Pharma、Chiesi、Wockhardt、DMS Pharmaceutical、Sandoz、Navinta、Teva、Shanghai Furen Medicine
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：20 mg / 200 mL、 40 mg / 200 mL
・用途別分析2017年-2028年：病院、クリニック、リカバリーセンター
・ニカルジピン塩酸塩注射の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・ニカルジピン塩酸塩注射のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・ニカルジピン塩酸塩注射のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ニカルジピン塩酸塩注射の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・ニカルジピン塩酸塩注射の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Nicardipine Hydrochloride Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nicardipine Hydrochloride Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Nicardipine Hydrochloride Injection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 20 mg / 200 mL segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Nicardipine Hydrochloride Injection include Baxter, Hikma, Mylan, Sun Pharma, and Chiesi, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Nicardipine Hydrochloride Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
20 mg / 200 mL
40 mg / 200 mL
Market segment by Application can be divided into
Hospital
Clinic
Recovery Center
The key market players for global Nicardipine Hydrochloride Injection market are listed below:
Baxter
Hikma
Mylan
Sun Pharma
Chiesi
Wockhardt
DMS Pharmaceutical
Sandoz
Navinta
Teva
Shanghai Furen Medicine
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nicardipine Hydrochloride Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nicardipine Hydrochloride Injection, with price, sales, revenue and global market share of Nicardipine Hydrochloride Injection from 2019 to 2022.
Chapter 3, the Nicardipine Hydrochloride Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nicardipine Hydrochloride Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nicardipine Hydrochloride Injection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nicardipine Hydrochloride Injection.
Chapter 13, 14, and 15, to describe Nicardipine Hydrochloride Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Nicardipine Hydrochloride Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nicardipine Hydrochloride Injection Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 20 mg / 200 mL
1.2.3 40 mg / 200 mL
1.3 Market Analysis by Application
1.3.1 Overview: Global Nicardipine Hydrochloride Injection Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Recovery Center
1.4 Global Nicardipine Hydrochloride Injection Market Size & Forecast
1.4.1 Global Nicardipine Hydrochloride Injection Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Nicardipine Hydrochloride Injection Sales in Volume (2017-2028)
1.4.3 Global Nicardipine Hydrochloride Injection Price (2017-2028)
1.5 Global Nicardipine Hydrochloride Injection Production Capacity Analysis
1.5.1 Global Nicardipine Hydrochloride Injection Total Production Capacity (2017-2028)
1.5.2 Global Nicardipine Hydrochloride Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nicardipine Hydrochloride Injection Market Drivers
1.6.2 Nicardipine Hydrochloride Injection Market Restraints
1.6.3 Nicardipine Hydrochloride Injection Trends Analysis
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Baxter Details
2.1.2 Baxter Major Business
2.1.3 Baxter Nicardipine Hydrochloride Injection Product and Services
2.1.4 Baxter Nicardipine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Hikma
2.2.1 Hikma Details
2.2.2 Hikma Major Business
2.2.3 Hikma Nicardipine Hydrochloride Injection Product and Services
2.2.4 Hikma Nicardipine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Nicardipine Hydrochloride Injection Product and Services
2.3.4 Mylan Nicardipine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sun Pharma
2.4.1 Sun Pharma Details
2.4.2 Sun Pharma Major Business
2.4.3 Sun Pharma Nicardipine Hydrochloride Injection Product and Services
2.4.4 Sun Pharma Nicardipine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Chiesi
2.5.1 Chiesi Details
2.5.2 Chiesi Major Business
2.5.3 Chiesi Nicardipine Hydrochloride Injection Product and Services
2.5.4 Chiesi Nicardipine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Wockhardt
2.6.1 Wockhardt Details
2.6.2 Wockhardt Major Business
2.6.3 Wockhardt Nicardipine Hydrochloride Injection Product and Services
2.6.4 Wockhardt Nicardipine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 DMS Pharmaceutical
2.7.1 DMS Pharmaceutical Details
2.7.2 DMS Pharmaceutical Major Business
2.7.3 DMS Pharmaceutical Nicardipine Hydrochloride Injection Product and Services
2.7.4 DMS Pharmaceutical Nicardipine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sandoz
2.8.1 Sandoz Details
2.8.2 Sandoz Major Business
2.8.3 Sandoz Nicardipine Hydrochloride Injection Product and Services
2.8.4 Sandoz Nicardipine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Navinta
2.9.1 Navinta Details
2.9.2 Navinta Major Business
2.9.3 Navinta Nicardipine Hydrochloride Injection Product and Services
2.9.4 Navinta Nicardipine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Teva
2.10.1 Teva Details
2.10.2 Teva Major Business
2.10.3 Teva Nicardipine Hydrochloride Injection Product and Services
2.10.4 Teva Nicardipine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Shanghai Furen Medicine
2.11.1 Shanghai Furen Medicine Details
2.11.2 Shanghai Furen Medicine Major Business
2.11.3 Shanghai Furen Medicine Nicardipine Hydrochloride Injection Product and Services
2.11.4 Shanghai Furen Medicine Nicardipine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Nicardipine Hydrochloride Injection Breakdown Data by Manufacturer
3.1 Global Nicardipine Hydrochloride Injection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Nicardipine Hydrochloride Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Nicardipine Hydrochloride Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Nicardipine Hydrochloride Injection Manufacturer Market Share in 2021
3.4.2 Top 6 Nicardipine Hydrochloride Injection Manufacturer Market Share in 2021
3.5 Global Nicardipine Hydrochloride Injection Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Nicardipine Hydrochloride Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nicardipine Hydrochloride Injection Market Size by Region
4.1.1 Global Nicardipine Hydrochloride Injection Sales in Volume by Region (2017-2028)
4.1.2 Global Nicardipine Hydrochloride Injection Revenue by Region (2017-2028)
4.2 North America Nicardipine Hydrochloride Injection Revenue (2017-2028)
4.3 Europe Nicardipine Hydrochloride Injection Revenue (2017-2028)
4.4 Asia-Pacific Nicardipine Hydrochloride Injection Revenue (2017-2028)
4.5 South America Nicardipine Hydrochloride Injection Revenue (2017-2028)
4.6 Middle East and Africa Nicardipine Hydrochloride Injection Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Nicardipine Hydrochloride Injection Sales in Volume by Type (2017-2028)
5.2 Global Nicardipine Hydrochloride Injection Revenue by Type (2017-2028)
5.3 Global Nicardipine Hydrochloride Injection Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Nicardipine Hydrochloride Injection Sales in Volume by Application (2017-2028)
6.2 Global Nicardipine Hydrochloride Injection Revenue by Application (2017-2028)
6.3 Global Nicardipine Hydrochloride Injection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Nicardipine Hydrochloride Injection Sales by Type (2017-2028)
7.2 North America Nicardipine Hydrochloride Injection Sales by Application (2017-2028)
7.3 North America Nicardipine Hydrochloride Injection Market Size by Country
7.3.1 North America Nicardipine Hydrochloride Injection Sales in Volume by Country (2017-2028)
7.3.2 North America Nicardipine Hydrochloride Injection Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Nicardipine Hydrochloride Injection Sales by Type (2017-2028)
8.2 Europe Nicardipine Hydrochloride Injection Sales by Application (2017-2028)
8.3 Europe Nicardipine Hydrochloride Injection Market Size by Country
8.3.1 Europe Nicardipine Hydrochloride Injection Sales in Volume by Country (2017-2028)
8.3.2 Europe Nicardipine Hydrochloride Injection Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Nicardipine Hydrochloride Injection Sales by Type (2017-2028)
9.2 Asia-Pacific Nicardipine Hydrochloride Injection Sales by Application (2017-2028)
9.3 Asia-Pacific Nicardipine Hydrochloride Injection Market Size by Region
9.3.1 Asia-Pacific Nicardipine Hydrochloride Injection Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Nicardipine Hydrochloride Injection Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Nicardipine Hydrochloride Injection Sales by Type (2017-2028)
10.2 South America Nicardipine Hydrochloride Injection Sales by Application (2017-2028)
10.3 South America Nicardipine Hydrochloride Injection Market Size by Country
10.3.1 South America Nicardipine Hydrochloride Injection Sales in Volume by Country (2017-2028)
10.3.2 South America Nicardipine Hydrochloride Injection Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nicardipine Hydrochloride Injection Sales by Type (2017-2028)
11.2 Middle East & Africa Nicardipine Hydrochloride Injection Sales by Application (2017-2028)
11.3 Middle East & Africa Nicardipine Hydrochloride Injection Market Size by Country
11.3.1 Middle East & Africa Nicardipine Hydrochloride Injection Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Nicardipine Hydrochloride Injection Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Nicardipine Hydrochloride Injection and Key Manufacturers
12.2 Manufacturing Costs Percentage of Nicardipine Hydrochloride Injection
12.3 Nicardipine Hydrochloride Injection Production Process
12.4 Nicardipine Hydrochloride Injection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Nicardipine Hydrochloride Injection Typical Distributors
13.3 Nicardipine Hydrochloride Injection Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Nicardipine Hydrochloride Injection Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Nicardipine Hydrochloride Injection Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Baxter Basic Information, Manufacturing Base and Competitors
Table 4. Baxter Major Business
Table 5. Baxter Nicardipine Hydrochloride Injection Product and Services
Table 6. Baxter Nicardipine Hydrochloride Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Hikma Basic Information, Manufacturing Base and Competitors
Table 8. Hikma Major Business
Table 9. Hikma Nicardipine Hydrochloride Injection Product and Services
Table 10. Hikma Nicardipine Hydrochloride Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Mylan Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Major Business
Table 13. Mylan Nicardipine Hydrochloride Injection Product and Services
Table 14. Mylan Nicardipine Hydrochloride Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Sun Pharma Major Business
Table 17. Sun Pharma Nicardipine Hydrochloride Injection Product and Services
Table 18. Sun Pharma Nicardipine Hydrochloride Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Chiesi Basic Information, Manufacturing Base and Competitors
Table 20. Chiesi Major Business
Table 21. Chiesi Nicardipine Hydrochloride Injection Product and Services
Table 22. Chiesi Nicardipine Hydrochloride Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 24. Wockhardt Major Business
Table 25. Wockhardt Nicardipine Hydrochloride Injection Product and Services
Table 26. Wockhardt Nicardipine Hydrochloride Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. DMS Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. DMS Pharmaceutical Major Business
Table 29. DMS Pharmaceutical Nicardipine Hydrochloride Injection Product and Services
Table 30. DMS Pharmaceutical Nicardipine Hydrochloride Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sandoz Basic Information, Manufacturing Base and Competitors
Table 32. Sandoz Major Business
Table 33. Sandoz Nicardipine Hydrochloride Injection Product and Services
Table 34. Sandoz Nicardipine Hydrochloride Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Navinta Basic Information, Manufacturing Base and Competitors
Table 36. Navinta Major Business
Table 37. Navinta Nicardipine Hydrochloride Injection Product and Services
Table 38. Navinta Nicardipine Hydrochloride Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Teva Basic Information, Manufacturing Base and Competitors
Table 40. Teva Major Business
Table 41. Teva Nicardipine Hydrochloride Injection Product and Services
Table 42. Teva Nicardipine Hydrochloride Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Shanghai Furen Medicine Basic Information, Manufacturing Base and Competitors
Table 44. Shanghai Furen Medicine Major Business
Table 45. Shanghai Furen Medicine Nicardipine Hydrochloride Injection Product and Services
Table 46. Shanghai Furen Medicine Nicardipine Hydrochloride Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Nicardipine Hydrochloride Injection Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 48. Global Nicardipine Hydrochloride Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Nicardipine Hydrochloride Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Nicardipine Hydrochloride Injection Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Nicardipine Hydrochloride Injection Production Site of Key Manufacturer
Table 52. Nicardipine Hydrochloride Injection New Entrant and Capacity Expansion Plans
Table 53. Nicardipine Hydrochloride Injection Mergers & Acquisitions in the Past Five Years
Table 54. Global Nicardipine Hydrochloride Injection Sales by Region (2017-2022) & (K Units)
Table 55. Global Nicardipine Hydrochloride Injection Sales by Region (2023-2028) & (K Units)
Table 56. Global Nicardipine Hydrochloride Injection Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Nicardipine Hydrochloride Injection Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Nicardipine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 59. Global Nicardipine Hydrochloride Injection Sales by Type (2023-2028) & (K Units)
Table 60. Global Nicardipine Hydrochloride Injection Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Nicardipine Hydrochloride Injection Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Nicardipine Hydrochloride Injection Price by Type (2017-2022) & (US$/Unit)
Table 63. Global Nicardipine Hydrochloride Injection Price by Type (2023-2028) & (US$/Unit)
Table 64. Global Nicardipine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 65. Global Nicardipine Hydrochloride Injection Sales by Application (2023-2028) & (K Units)
Table 66. Global Nicardipine Hydrochloride Injection Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Nicardipine Hydrochloride Injection Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Nicardipine Hydrochloride Injection Price by Application (2017-2022) & (US$/Unit)
Table 69. Global Nicardipine Hydrochloride Injection Price by Application (2023-2028) & (US$/Unit)
Table 70. North America Nicardipine Hydrochloride Injection Sales by Country (2017-2022) & (K Units)
Table 71. North America Nicardipine Hydrochloride Injection Sales by Country (2023-2028) & (K Units)
Table 72. North America Nicardipine Hydrochloride Injection Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Nicardipine Hydrochloride Injection Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Nicardipine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 75. North America Nicardipine Hydrochloride Injection Sales by Type (2023-2028) & (K Units)
Table 76. North America Nicardipine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 77. North America Nicardipine Hydrochloride Injection Sales by Application (2023-2028) & (K Units)
Table 78. Europe Nicardipine Hydrochloride Injection Sales by Country (2017-2022) & (K Units)
Table 79. Europe Nicardipine Hydrochloride Injection Sales by Country (2023-2028) & (K Units)
Table 80. Europe Nicardipine Hydrochloride Injection Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Nicardipine Hydrochloride Injection Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Nicardipine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 83. Europe Nicardipine Hydrochloride Injection Sales by Type (2023-2028) & (K Units)
Table 84. Europe Nicardipine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 85. Europe Nicardipine Hydrochloride Injection Sales by Application (2023-2028) & (K Units)
Table 86. Asia-Pacific Nicardipine Hydrochloride Injection Sales by Region (2017-2022) & (K Units)
Table 87. Asia-Pacific Nicardipine Hydrochloride Injection Sales by Region (2023-2028) & (K Units)
Table 88. Asia-Pacific Nicardipine Hydrochloride Injection Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Nicardipine Hydrochloride Injection Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Nicardipine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 91. Asia-Pacific Nicardipine Hydrochloride Injection Sales by Type (2023-2028) & (K Units)
Table 92. Asia-Pacific Nicardipine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 93. Asia-Pacific Nicardipine Hydrochloride Injection Sales by Application (2023-2028) & (K Units)
Table 94. South America Nicardipine Hydrochloride Injection Sales by Country (2017-2022) & (K Units)
Table 95. South America Nicardipine Hydrochloride Injection Sales by Country (2023-2028) & (K Units)
Table 96. South America Nicardipine Hydrochloride Injection Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Nicardipine Hydrochloride Injection Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Nicardipine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 99. South America Nicardipine Hydrochloride Injection Sales by Type (2023-2028) & (K Units)
Table 100. South America Nicardipine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 101. South America Nicardipine Hydrochloride Injection Sales by Application (2023-2028) & (K Units)
Table 102. Middle East & Africa Nicardipine Hydrochloride Injection Sales by Region (2017-2022) & (K Units)
Table 103. Middle East & Africa Nicardipine Hydrochloride Injection Sales by Region (2023-2028) & (K Units)
Table 104. Middle East & Africa Nicardipine Hydrochloride Injection Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Nicardipine Hydrochloride Injection Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Nicardipine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 107. Middle East & Africa Nicardipine Hydrochloride Injection Sales by Type (2023-2028) & (K Units)
Table 108. Middle East & Africa Nicardipine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 109. Middle East & Africa Nicardipine Hydrochloride Injection Sales by Application (2023-2028) & (K Units)
Table 110. Nicardipine Hydrochloride Injection Raw Material
Table 111. Key Manufacturers of Nicardipine Hydrochloride Injection Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Nicardipine Hydrochloride Injection Typical Distributors
Table 115. Nicardipine Hydrochloride Injection Typical Customers
List of Figures
Figure 1. Nicardipine Hydrochloride Injection Picture
Figure 2. Global Nicardipine Hydrochloride Injection Revenue Market Share by Type in 2021
Figure 3. 20 mg / 200 mL
Figure 4. 40 mg / 200 mL
Figure 5. Global Nicardipine Hydrochloride Injection Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Recovery Center
Figure 9. Global Nicardipine Hydrochloride Injection Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Nicardipine Hydrochloride Injection Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Nicardipine Hydrochloride Injection Sales (2017-2028) & (K Units)
Figure 12. Global Nicardipine Hydrochloride Injection Price (2017-2028) & (US$/Unit)
Figure 13. Global Nicardipine Hydrochloride Injection Production Capacity (2017-2028) & (K Units)
Figure 14. Global Nicardipine Hydrochloride Injection Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Nicardipine Hydrochloride Injection Market Drivers
Figure 16. Nicardipine Hydrochloride Injection Market Restraints
Figure 17. Nicardipine Hydrochloride Injection Market Trends
Figure 18. Global Nicardipine Hydrochloride Injection Sales Market Share by Manufacturer in 2021
Figure 19. Global Nicardipine Hydrochloride Injection Revenue Market Share by Manufacturer in 2021
Figure 20. Nicardipine Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Nicardipine Hydrochloride Injection Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Nicardipine Hydrochloride Injection Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Nicardipine Hydrochloride Injection Sales Market Share by Region (2017-2028)
Figure 24. Global Nicardipine Hydrochloride Injection Revenue Market Share by Region (2017-2028)
Figure 25. North America Nicardipine Hydrochloride Injection Revenue (2017-2028) & (USD Million)
Figure 26. Europe Nicardipine Hydrochloride Injection Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Nicardipine Hydrochloride Injection Revenue (2017-2028) & (USD Million)
Figure 28. South America Nicardipine Hydrochloride Injection Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Nicardipine Hydrochloride Injection Revenue (2017-2028) & (USD Million)
Figure 30. Global Nicardipine Hydrochloride Injection Sales Market Share by Type (2017-2028)
Figure 31. Global Nicardipine Hydrochloride Injection Revenue Market Share by Type (2017-2028)
Figure 32. Global Nicardipine Hydrochloride Injection Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Nicardipine Hydrochloride Injection Sales Market Share by Application (2017-2028)
Figure 34. Global Nicardipine Hydrochloride Injection Revenue Market Share by Application (2017-2028)
Figure 35. Global Nicardipine Hydrochloride Injection Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Nicardipine Hydrochloride Injection Sales Market Share by Type (2017-2028)
Figure 37. North America Nicardipine Hydrochloride Injection Sales Market Share by Application (2017-2028)
Figure 38. North America Nicardipine Hydrochloride Injection Sales Market Share by Country (2017-2028)
Figure 39. North America Nicardipine Hydrochloride Injection Revenue Market Share by Country (2017-2028)
Figure 40. United States Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Nicardipine Hydrochloride Injection Sales Market Share by Type (2017-2028)
Figure 44. Europe Nicardipine Hydrochloride Injection Sales Market Share by Application (2017-2028)
Figure 45. Europe Nicardipine Hydrochloride Injection Sales Market Share by Country (2017-2028)
Figure 46. Europe Nicardipine Hydrochloride Injection Revenue Market Share by Country (2017-2028)
Figure 47. Germany Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Nicardipine Hydrochloride Injection Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Nicardipine Hydrochloride Injection Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Nicardipine Hydrochloride Injection Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Nicardipine Hydrochloride Injection Revenue Market Share by Region (2017-2028)
Figure 56. China Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Nicardipine Hydrochloride Injection Sales Market Share by Type (2017-2028)
Figure 63. South America Nicardipine Hydrochloride Injection Sales Market Share by Application (2017-2028)
Figure 64. South America Nicardipine Hydrochloride Injection Sales Market Share by Country (2017-2028)
Figure 65. South America Nicardipine Hydrochloride Injection Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Nicardipine Hydrochloride Injection Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Nicardipine Hydrochloride Injection Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Nicardipine Hydrochloride Injection Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Nicardipine Hydrochloride Injection Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Nicardipine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Nicardipine Hydrochloride Injection in 2021
Figure 77. Manufacturing Process Analysis of Nicardipine Hydrochloride Injection
Figure 78. Nicardipine Hydrochloride Injection Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のニカルジピン塩酸塩注射市場2022年：20 mg / 200 mL、 40 mg / 200 mL(Global Nicardipine Hydrochloride Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ナルメフェン塩酸塩注射液のグローバル市場予測2023-2029
  • ニカルジピン塩酸塩APIのグローバル市場予測2023-2029
  • エピルビシン塩酸塩注射液のグローバル市場2023年：5mg、10mg
  • 注射用塩酸クリンダマイシンのグローバル市場2023年：筋肉注射、点滴
  • 世界のオンダンセトロン塩酸塩注射剤市場2022年：2ml /バイアル、20ml/バイアル